文献速递肝病

美国酒精相关性肝病肝移植中心实践异质性调查

Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States.
PubMed 文献 · Am J Gastroenterol · 2022-08-01

该研究对美国117家成人肝移植中心进行网络调查,收集100份回复(85.5%),覆盖所有器官获取与移植网络区域。结果显示70.0%的中心对酒精性肝硬化无最低戒酒时间要求,21.0%要求戒酒6个月;85.0%的中心为严重酒精性肝炎行肝移植;移植前后酒精使用监测方案各中心不同。

要点

  • 70.0%的肝移植中心对酒精性肝硬化无最低戒酒时间要求,21.0%要求戒酒6个月。
  • 85.0%的中心为严重酒精性肝炎行肝移植。
  • 各中心移植前后酒精使用监测方案存在差异。

核心结论

  • 研究结果突显各中心对酒精相关性肝病肝移植的态度发生变化,尤其是对严重酒精性肝炎。

研究设计与样本

  • 对美国成人肝移植中心进行网络调查,共117家中心,收集100份回复(85.5%),覆盖所有器官获取与移植网络区域。

主要发现

  • 对于酒精性肝硬化,70.0%的中心报告无最低戒酒时间要求,21.0%要求戒酒6个月。
  • 85.0%的中心为严重酒精性肝炎行肝移植。
  • 各中心移植前后酒精使用监测方案存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Alcohol-related liver disease (ALD) is now the leading indication for liver transplantation (LT) in the United States (US). It remains unclear how centers are managing the medical and psychosocial issues associated with these patients. METHODS: We conducted a web-based survey of LT centers in the United States to identify center-level details on peri-LT management of ALD and related issues. RESULTS: Of the 117 adult LT centers, 100 responses (85.5%) were collected, representing all Organ Procurement and Transplantation Network regions. For alcohol-associated cirrhosis, 70.0% of the centers reported no minimum sobriety requirement while 21.0% required 6 months of sobriety. LT for severe alcohol-associated hepatitis was performed at 85.0% of the centers. Monitoring protocols for pre-LT and post-LT alcohol use varied among centers. DISCUSSION: Our findings highlight a change in center attitudes toward LT for ALD, particularly for severe alcohol-associated hepatitis.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lim N, Kwong AJ, Jafri SM, et al. Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol. 2022. PMID: 35916539. doi:10.14309/ajg.0000000000001863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。